The store will not work correctly when cookies are disabled.
(R)-4-cyclopropyl-2-methyl-9-phenethyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one
ID: ALA4789005
PubChem CID: 118560973
Max Phase: Preclinical
Molecular Formula: C20H28N2O2
Molecular Weight: 328.46
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: C[C@H]1OC2(CCN(CCc3ccccc3)CC2)CN(C2CC2)C1=O
Standard InChI: InChI=1S/C20H28N2O2/c1-16-19(23)22(18-7-8-18)15-20(24-16)10-13-21(14-11-20)12-9-17-5-3-2-4-6-17/h2-6,16,18H,7-15H2,1H3/t16-/m1/s1
Standard InChI Key: BZPKTOXVMUIFBK-MRXNPFEDSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
27.8258 -10.2314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8216 -11.0486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5234 -11.4585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2338 -11.0557 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.2379 -10.2385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5316 -9.8241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4184 -9.4142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4184 -10.2314 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.1237 -10.6359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8289 -9.4142 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.1237 -9.0015 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1237 -8.1843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7095 -9.0077 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.9388 -11.4689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6491 -11.0648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3542 -11.4780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3465 -12.2960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0508 -12.7091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7621 -12.3050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7647 -11.4836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0599 -11.0742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7122 -10.6415 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8997 -10.6452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3098 -11.3514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 1 0
7 11 1 0
8 9 1 0
9 1 1 0
1 10 1 0
10 11 1 0
11 12 1 1
7 13 2 0
4 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
8 22 1 0
23 22 1 0
24 23 1 0
22 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 328.46 | Molecular Weight (Monoisotopic): 328.2151 | AlogP: 2.47 | #Rotatable Bonds: 4 |
Polar Surface Area: 32.78 | Molecular Species: BASE | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.99 | CX LogP: 2.07 | CX LogD: 0.47 |
Aromatic Rings: 1 | Heavy Atoms: 24 | QED Weighted: 0.85 | Np Likeness Score: -0.30 |
References
1. García M,Virgili M,Alonso M,Alegret C,Farran J,Fernández B,Bordas M,Pascual R,Burgueño J,Vidal-Torres A,Fernández de Henestrosa AR,Ayet E,Merlos M,Vela JM,Plata-Salamán CR,Almansa C. (2020) Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ Receptor Antagonist Clinical Candidate for the Treatment of Pain., 63 (24): [PMID:33064947] [10.1021/acs.jmedchem.0c01127] |